Astra Zeneca Agrees to Lower Drug Prices in the US

Updated:

Published:

Astra Zeneca Agrees to Lower Drug Prices in the US
Photo: Alex Brandon/AP/TT

USA has entered into an agreement with the multinational Astra Zeneca to lower drug prices in the USA, announces the pharmaceutical company and USA's president Donald Trump.

The agreement includes a pricing model that aims to make prescription drugs more affordable for low-income earners, including those covered by the state health insurance Medicaid.

At the press conference in the Oval Office, in addition to US President Donald Trump, Astra Zeneca's CEO Pascal Soriot was also present.

The pharmaceutical company, which is based in the United Kingdom, will also invest $50 billion in its drug manufacturing, research and development in the US.

Trump calls the agreement a "tremendous victory for American patients and for the country".

The agreement comes after competitor Pfizer entered into a similar price agreement with the Trump administration to lower prices on several drugs in the US to avoid drug tariffs for three years.

Loading related articles...

Tags

Author

TTT
By TTEnglish edition by Sweden Herald, adapted for our readers

More news

Loading related posts...